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DISCUSSION
Dr Michael J. Costanza (Syracuse, NY). Dr Baril and the
Mount Sinai group have addressed an important problem that
virtually every vascular specialist has faced: how to manage renal
artery stenosis in a patient awaiting or undergoing an endovascular
abdominal aortic aneurysm repair. The decision-making on these
patients can be challenging for several reasons, which you have
clearly outlined in your paper.
Your results indicate that renal artery stenting before, during
and after EVAR is feasible even with transrenal fixation devices. I
am convinced that we can perform renal artery stenting in these
patients, but I’d like you to tell us if we should be doing this.
My first question is about the natural history of renal artery
stenosis and EVAR. Have you looked at your center’s over 900
endovascular aneurysm repairs to identify and track patients with
renal artery stenosis who are managed medically after their EVAR?
This information would be helpful in determining how aggres-
sively we should look for and treat renal artery stenosis in these
patients.
Secondly, did renal artery stenting confer any clinical benefits
for these treated patients? Was their blood pressure controlled with
fewer medications? Did they have a slower rate of renal decline?
Although you did not detect a change in creatinine clearance in
your series, creatinine can be an insensitive indicator for renal
function. Also, only a third of your patients had renal insufficiency,
which implies that the majority of patients either were hypertensive
or asymptomatic.
And finally, detailed CT scans and CT angiograms have made
preoperative angiography unnecessary for many patients awaiting
EVAR. How would you suggest that these patients be managed
with respect to evaluating them for renal artery stenosis? Is it
reasonable to identify and treat renal artery stenosis at the time of
an endovascular aneurysm repair or should they be treated in a
staged fashion?
Dr Donald T. Baril. In reference to your first question, as to
whether we have looked at the natural history of renal stenosis in
these patients, we have previously, and observed that essentially
patients with renal artery stenosis with a transrenal aortic endograft
tend to have the same natural course as if the graft is not there.
They have progression of the disease, but not at a rate higher than
would be expected without the presence of the endograft.
That being said, the patients that we choose to place renal
artery stents in preoperatively are those that have high-grade
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stenosis greater than 90%. Even in asymptomatic patients we had a
concern of atheroembolic events at the time of aortic endograft
deployment.
Additionally, patients with 70% or greater stenosis in the
setting of clinical hypertension or renal insufficiency have also been
stented.
In reference to your second question of the clinical benefits,
that was not specifically examined in this series. There are anecdotal
reports from our own institution that some patients have been
weaned off antihypertensives whereas others have continued to
require equal or greater doses. However, the patients with renal
insufficiency who underwent renal artery stenting have basically
maintained their renal function.
Finally, in reference to your last question, our institution has
continued to do preoperative angiography for a number of differ-
ent reasons. One is the belief that this is the best means of
measuring aneurysm and aortic length. Additionally, a large num-
ber of our cases are referred to our tertiary referral center and
require adjuvant therapy, whether it be a renal artery stent or
hypogastric embolization, before endograft deployment.
That being said, if a renal artery lesion is found on CT
angiography, the next step would be to perform a renal artery
duplex to determine the clinical significance of the stenosis. Based
on the results of the duplex, we would recommend a staged
procedure to minimize operative time as well as contrast load in
what is often a renal insufficient population.
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